MSD Netherlands operates as a key production and distribution center for pharmaceuticals, packaging and distributing 2,500 different medicines and vaccines to over 140 countries from its Haarlem facility. Established in the Netherlands in 1954, it focuses on flexible packaging of pharmaceutical products and serves as a major hub for Europe and global markets. As part of the global MSD biopharmaceutical company, it emphasizes quality standards in manufacturing and distribution.

Products & services

Medicines Pharmaceutical products developed to treat a variety of human diseases and health conditions.
Vaccines Biological preparations designed to prevent infectious diseases by stimulating the immune system.
Biologic Therapies Therapeutic products derived from biological sources used to treat complex diseases including cancer and immune disorders.
Animal Health Products Medicines and vaccines developed for the prevention and treatment of diseases in animals.
Clinical Trials Services Research studies conducted to evaluate the safety and efficacy of new medicines and vaccines.
Winrevair (sotatercept) A PAH treatment using activin signalling inhibition to improve exercise capacity in adults with pulmonary arterial hypertension.

Leadership

Jim Beitel Chief Business Officer
Sherine Z. Galal Finance Lead & CFO
Evin Allen Knowledge Management Lead
Emma Cerrone Executive Director, Agile and Digital Fitness Lead, Global Digital Accelerator
George Merck Founder

Seniority mix

Entry & junior 25%
Mid-level 12%
Senior 24%
Lead & principal 3%
Manager & above 36%

Based on 67 open roles

Work at MSD.

Open roles at MSD

Subscribe to Career Resources.

Your cookie choices